Literature DB >> 27019545

Potent P2X7 Receptor Antagonists: Tyrosyl Derivatives Synthesized Using a Sequential Parallel Synthetic Approach.

R Gnana Ravi1, Sylvia B Kertesy2, George R Dubyak2, Kenneth A Jacobson1.   

Abstract

Novel analogs of 1-(N,O-bis[5-isoquinolinesulfonyl]-N-methyl-L-tyrosyl)-4-phenylpiperazine (KN-62,1) were synthesized and found to be potent antagonists in a functional assay, inhibition of ATP-induced K+ efflux in HEK293 cells expressing recombinant human P2X7 receptors. Antagonism of murine P2X7 receptors was also observed. The analogs consisted of L-tyrosine derivatives, of the general structure R1-Tyr(OR2)-piperazinyl-R3, in which three positions were systematically varied in structure through facile acylation reactions. Each of the three positions was optimized in sequence through parallel synthesis alternating with biological evaluation, leading to the identification and optimization of potent P2X7 antagonists. The optimal groups at R1 were found to be large hydrophobic groups, linked to the α-amino position through carbamate, amide, or sulfonamide groups. The benzyloxycarbonyl (Cbz) group was preferred over most sulfonamides and other acyl groups examined, except for quinoline sulfonyl. At R2, an arylsulfonate ester was preferred, and the order of potency was p-tolyl, p-methoxyphenyl, phenyl > α-naphthyl, β-naphthyl. A benzoyl ester was of intermediate potency. Aliphatic esters and carbonate derivatives at the tyrosyl phenol were inactive, while a tyrosyl O-benzyl ether was relatively potent. The most potent P2X7 receptor antagonists identified in this study contained Cbz at the R1 position, an aryl sulfonate at the R2 position, and various acyl groups at the R3 position. At R3, t-butyloxycarbonyl- and benzoyl groups were preferred. The opening of the piperazinyl ring to an ethylene diamine moiety abolished antagonism. In concentration-response studies, a di-isoquinolinyl, Boc derivative, 4 (MRS2306), displayed an IC50 value of 40 nM as an antagonist of P2X7 receptor-mediated ion flux and was more potent than the reference compound 1. Nα-Cbz, Boc-piperazinyl derivatives, 11 (MRS2317), 22 (MRS2326), and 41 (MRS2409) were less potent than 1, with IC50 values of 200-300 nM.

Entities:  

Keywords:  KN-62; ion channels; isoquinolines; nucleotides; purines; structure activity relationships

Year:  2001        PMID: 27019545      PMCID: PMC4807024          DOI: 10.1002/ddr.1207

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  27 in total

1.  ATP-stimulated Ca2+ influx and phospholipase D activities of a rat brain-derived type-2 astrocyte cell line, RBA-2, are mediated through P2X7 receptors.

Authors:  S H Sun; L B Lin; A C Hung; J S Kuo
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

2.  P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells.

Authors:  D Ferrari; C Stroh; K Schulze-Osthoff
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

3.  Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners.

Authors:  G E Torres; T M Egan; M M Voigt
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

4.  Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

Authors:  Y C Kim; M de Zwart; L Chang; S Moro; J K von Frijtag Drabbe Künzel; N Melman; A P IJzerman; K A Jacobson
Journal:  J Med Chem       Date:  1998-07-16       Impact factor: 7.446

5.  Towards a revised nomenclature for P1 and P2 receptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; G R Dubyak; T K Harden; K A Jacobson; U Schwabe; M Williams
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

6.  Upregulation of P2X(7) receptor currents in Müller glial cells during proliferative vitreoretinopathy.

Authors:  A Bringmann; T Pannicke; V Moll; I Milenkovic; F Faude; V Enzmann; S Wolf; A Reichenbach
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

7.  KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.

Authors:  H Tokumitsu; T Chijiwa; M Hagiwara; A Mizutani; M Terasawa; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

8.  P2Z/P2X7 receptor-dependent apoptosis of dendritic cells.

Authors:  R Coutinho-Silva; P M Persechini; R D Bisaggio; J L Perfettini; A C Neto; J M Kanellopoulos; I Motta-Ly; A Dautry-Varsat; D M Ojcius
Journal:  Am J Physiol       Date:  1999-05

9.  Altered cytokine production in mice lacking P2X(7) receptors.

Authors:  M Solle; J Labasi; D G Perregaux; E Stam; N Petrushova; B H Koller; R J Griffiths; C A Gabel
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

10.  Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor.

Authors:  P G Baraldi; R Romagnoli; M A Tabrizi; S Falzoni; F di Virgilio
Journal:  Bioorg Med Chem Lett       Date:  2000-04-03       Impact factor: 2.823

View more
  1 in total

1.  Functionalized congeners of tyrosine-based P2X(7) receptor antagonists: probing multiple sites for linking and dimerization.

Authors:  Wangzhong Chen; R Gnana Ravi; Sylvia B Kertesy; George R Dubyak; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2002 Sep-Oct       Impact factor: 4.774

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.